AFB/TB Susceptibility : Rifabutin (Rapid- MGIT)

Rapid Mycobacteria Growth Indicator Tube (MGIT) for Rifabutin susceptibility is an innovative diagnostic test that rapidly and accurately detects resistance to the antibiotic rifabutin in Mycobacterium tuberculosis, the bacterium responsible for Tuberculosis (TB).

TB is a severe infectious disease that primarily affects the lungs, although it can affect other parts of the body as well. The first line of defense in treating TB typically includes rifabutin. However, the emergence of drug-resistant strains of Mycobacterium tuberculosis necessitates testing the susceptibility of the TB bacteria to this antibiotic.

  • Test Name AFB/TB Susceptibility : Rifabutin (Rapid- MGIT)
  • Sample Type Sputum or other body fluid sample
  • Preparations Required No special preparation required.
  • Report Time 4 weeks

Home Sample Collection Process
Book your convenient slot
Book your convenient slot
Sample Collection by Phlebotomist
Sample Collection by Phlebotomist
Reporting of the sample at lab
Reporting of the sample at lab
Download Reports
Download Reports
Frequently Asked Questions

The test is used to determine whether the TB bacteria, Mycobacterium tuberculosis, is resistant to the antibiotic rifabutin. The results of this test help doctors to provide the most effective treatment for TB patients.

No, fasting is not required for this test.

No special preparation is necessary for this test.

This test is typically recommended if you have been diagnosed with tuberculosis and the disease is not responding as expected to treatment, indicating potential drug resistance.

This test measures the growth of Mycobacterium tuberculosis in the presence of rifabutin, indicating whether the bacteria are resistant or susceptible to the antibiotic.

This test is generally performed once when TB treatment begins, or if there is suspicion of drug resistance.

Normal results show that the Mycobacterium tuberculosis is susceptible to rifabutin, suggesting that the drug should be effective in treating the disease.

If your results indicate resistance to rifabutin, your doctor will likely adjust your treatment plan to include antibiotics that the bacteria have shown susceptibility to.

The test results can be affected by certain laboratory conditions, such as the temperature and incubation period, and the quality of the sample provided.

If your test results are abnormal, it's important to immediately consult with your doctor. They may adjust your medications based on the test results to ensure effective treatment.

While lifestyle changes do not directly influence the test results, sticking to your TB medication regimen can help prevent the development of drug-resistant TB.

Yes, non-modifiable factors, such as the strain of Mycobacterium tuberculosis and its inherent resistance or susceptibility to the drug, can affect the test results.

Those at risk for drug-resistant TB include people who do not take their TB medication as prescribed, those who have been previously treated for TB, and people who have been in close contact with patients with drug-resistant TB.

Yes, drug-resistant TB can be treated, but it requires longer treatment times and medications that often have more side effects.

You should consult a pulmonologist or an infectious disease specialist if your test results are abnormal.

Detecting drug-resistant strains of TB early through the use of advanced diagnostic tests such as AFB/TB Susceptibility: Rifabutin (Rapid- MGIT) can significantly improve the effectiveness of treatment strategies and enhance patient outcomes. If you have been diagnosed with TB, make sure you take your medication as prescribed and monitor your condition closely with your doctor.

AFB/TB Susceptibility : Rifabutin (Rapid- MGIT)
₹ 2600
Book Your Slot
Locations Near You in Hyderabad
  • 4KM from Madhapur
  • 3KM from Banjara Hills
  • 1.9KM from Yusufguda
  • 3KM from Madhura Nagar
  • 5KM from Shaikpet